Methazolamide

CAS No. 554-57-4

Methazolamide( Methazolamide | Neptazane | Methenamide | Neptazaneat | Naptazane | N Methylacetazolamide )

Catalog No. M15015 CAS No. 554-57-4

Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 43 In Stock
200MG 55 In Stock
500MG 67 In Stock
1G 86 In Stock

Biological Information

  • Product Name
    Methazolamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.
  • Description
    Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma. Target: Carbonic Anhydrase Methazolamide is a carbonic anhydrase inhibitor with Ki of 50 nM, 14 nM and 36 nM for hCA I, hCA II and bCA IV isoforms, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Methazolamide | Neptazane | Methenamide | Neptazaneat | Naptazane | N Methylacetazolamide
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Carbonic Anhydrase
  • Recptor
    bCAIV| hCAI| hCAII
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    554-57-4
  • Formula Weight
    236.27
  • Molecular Formula
    C5H8N4O3S2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 3 mg/mL (12.69 mM); DMSO: 47 mg/mL (198.92 mM)
  • SMILES
    CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
  • Chemical Name
    N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Casini A, et al. Bioorg Med Chem Lett, 2003, 13(5), 841-845.
molnova catalog
related products
  • Hydrochlorothiazide

    Hydrochlorothiazide is a first line diuretic compound of the thiazide class.

  • Dimethylfraxetin

    Dimethylfraxetin is a?Carbonic anhydrase?inhibitor(Ki:0.0097 μM)

  • Levosimendan

    Levosimendan is a calcium sensitizer acting through calcium-dependent binding to cardiac troponin C (cTnC), provides treatment for heart failure.